Limba
|
Derazantinib is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR)with IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3, showing lower potency for FGFR4 (IC50=34 nM). It also inhibits RET, DDR2, PDGFRβ, VEGFR and KIT.
Price | 2.846,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Derazantinib is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR)with IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3, showing lower potency for FGFR4 (IC50=34 nM). It also inhibits RET, DDR2, PDGFRβ, VEGFR and KIT. |